Table 3.
Stone Former | Plasma Uric Acid Level | Number of Participants | Number of CKD Events | CKD Events per 1,000 Person-Years (95% CI) | Model 1, Hazard Ratio (95% CI) | Model 2, Hazard Ratio (95% CI) |
---|---|---|---|---|---|---|
Time-varying analyses | ||||||
Yes | >6 | 452 | 53 | 11.2 (8.6 to 14.7) | 1.48 (1.11 to 1.98)a | 0.94 (0.70 to 1.28) |
≤6 | 717 | 85 | 11.5 (9.3 to 14.2) | 1.65 (1.31 to 2.08)a | 1.34 (1.05 to 1.72)a | |
No | >6 | 3109 | 409 | 11.0 (10.0 to 12.1) | 1.54 (1.34 to 1.76)a | 1.11 (0.96 to 1.28) |
≤6 | 6330 | 479 | 6.1 (5.6 to 6.7) | 1 (reference) | 1 (reference) | |
Baseline analyses | ||||||
Yes | >6 | 321 | 37 | 9.8 (7.1 to 13.6) | 1.35 (0.96 to 1.89) | 0.83 (0.58 to 1.19) |
≤6 | 528 | 67 | 10.9 (8.5 to 13.8) | 1.58 (1.22 to 2.04)a | 1.22 (0.93 to 1.61) | |
No | >6 | 3240 | 432 | 11.4 (10.4 to 12.5) | 1.54 (1.34 to 1.76)a | 1.10 (0.95 to 1.27) |
≤6 | 6519 | 502 | 6.3 (5.8 to 6.9) | 1 (reference) | 1 (reference) |
Uric acid levels were missing in 70 participants at visit 4. Model 1 was adjusted for age, sex, race, and study center. Model 2 was adjusted for the demographic factors in model 1 as well as HDL, hypertension, urine albumin-to-creatinine ratio, eGFR, plasma uric acid (linear spline with knot at 6 mg/dl), diuretic use, smoking status, body mass index, diabetes, history of coronary heart disease, and high-sensitivity C-reactive protein. 95% CI, 95% confidence interval.
P<0.05.